SCHEMBL1380708

SCHEMBL1380708

CCCOc1cc(Oc2ccc(C(=O)N3CCC3)nc2)cc(C(=O)Nc2nccs2)c1

nearest known ligand 0.61

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCK P35557 20/20 0.61
KCNH2 Q12809 3/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1380706 0.87 GCK (0.69) GCKKCNH2
SCHEMBL1427002 0.86 GCK (0.73) GCKKCNH2
SCHEMBL1379660 0.86 GCK (0.82) GCKKCNH2
SCHEMBL2650439 0.84 GCK (0.66) GCKKCNH2
SCHEMBL2650604 0.83 GCK (0.63) GCKKCNH2
SCHEMBL2652826 0.83 GCK (0.65) GCKKCNH2
SCHEMBL1492957 0.82 GCK (0.58) GCKKCNH2
SCHEMBL2652560 0.82 GCK (0.64) GCKKCNH2
SCHEMBL2656834 0.82 GCK (0.52) GCKKCNH2
SCHEMBL1493733 0.81 GCK (0.65) GCKKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4651714-B2 2011-03-16 JP claimed
EP-1902052-A1 HETEROARYL BENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES AstraZeneca AB (SE) 2008-03-26 EP claimed
WO-2007007041-A1 HETEROARYL BENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES ASTRAZENECA AB (SE) 2007-01-18 WO claimed